Benzinga

MARCH 27, 2024

Tuesday, Shockwave Medical Inc (NASDAQ: SWAV ) shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson (NYSE: JNJ ) is reportedly in talks to acquire the company. Shockwave Medical is a cardiovascular medical device. for an upfront payment of $380.00 billion.

Enterprise Value 98

Enterprise Value Marketability 98

Law 360 M&A

MAY 8, 2024

A shareholder of cardiovascular treatment company Shockwave Medical Inc. is attempting to halt the company's "unfair" $13 billion proposed transaction with Johnson & Johnson by filing a securities suit, saying the transaction will only benefit company insiders and damage public shareholders.

52

52

Benzinga

APRIL 5, 2024

Friday, Johnson & Johnson (NYSE: JNJ ) agreed to acquire Shockwave Medical Inc (NASDAQ: SWAV ) for $335.00 In November 2023, Johnson & Johnson MedTech acquired Laminar Inc., The acquisition of Shockwave Medical further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and.

Enterprise Value 59

Enterprise Value 59

Law 360 M&A

APRIL 5, 2024

Freshfields Bruckhaus Deringer-led Johnson & Johnson has agreed to buy Fenwick & West-advised Shockwave Medical Inc., billion, the companies said Friday. a provider of a cardiovascular blood flow treatment, at an enterprise value of $13.1

Enterprise Value 52

Enterprise Value 52

Benzinga

JANUARY 17, 2023

Shockwave Medical Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Full Year 2023 Revenue Guidance. 17, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. NASDAQ, TSX: NVCN ), a company focused on the minimally invasive treatment of refractory angina. SANTA CLARA, Calif., and the E.U.

Enterprise Value 40

Enterprise Value Marketability Technology 40

Benzinga

JANUARY 17, 2023

The team at Shockwave has demonstrated an extraordinary ability to scale novel technologies and build value for patients, customers and investors, and we are thrilled to become a part of their organization." VANCOUVER, BC, Jan. Under the terms of the Arrangement Agreement, Neovasc shareholders will receive US$27.25

Enterprise Value 40

Enterprise Value Marketability Technology 40

Benzinga

MARCH 6, 2023

Shockwave") by way of a statutory plan of arrangement (the "Arrangement") at the special meeting of Shareholders held today (the "Meeting"). Until the closing of the Arrangement, the parties remain separate independent companies. The Company will also deregister the Shares under the U.S.

Marketability 40

Marketability 40